IRIS Accounts Production v24.2.0.383 10497591 director 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104975912022-11-30104975912023-11-30104975912022-12-012023-11-30104975912021-11-30104975912021-12-012022-11-30104975912022-11-3010497591ns15:EnglandWales2022-12-012023-11-3010497591ns14:PoundSterling2022-12-012023-11-3010497591ns10:Director12022-12-012023-11-3010497591ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3010497591ns10:SmallEntities2022-12-012023-11-3010497591ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3010497591ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3010497591ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3010497591ns10:AbridgedAccounts2022-12-012023-11-3010497591ns10:RegisteredOffice2022-12-012023-11-3010497591ns5:CurrentFinancialInstruments2023-11-3010497591ns5:CurrentFinancialInstruments2022-11-3010497591ns5:Non-currentFinancialInstruments2023-11-3010497591ns5:Non-currentFinancialInstruments2022-11-3010497591ns5:ShareCapital2023-11-3010497591ns5:ShareCapital2022-11-3010497591ns5:RetainedEarningsAccumulatedLosses2023-11-3010497591ns5:RetainedEarningsAccumulatedLosses2022-11-3010497591ns5:FurnitureFittings2022-12-012023-11-3010497591ns5:MotorVehicles2022-12-012023-11-3010497591ns5:ComputerEquipment2022-12-012023-11-30
REGISTERED NUMBER: 10497591 (England and Wales)















ABRIDGED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2023

FOR

TOTAL BLEED SOLUTIONS LIMITED

TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


TOTAL BLEED SOLUTIONS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTOR: Mr. B. M. Clarke





REGISTERED OFFICE: 11 Rowen Close
Ingleby Barwick
Stockton-on-Tees
TS17 5DX





REGISTERED NUMBER: 10497591 (England and Wales)





ACCOUNTANTS: Baines Jewitt Limited
Chartered Accountants
Spitfire House
19 Falcon Court
Preston Farm Industrial Estate
Stockton-on-Tees
TS18 3TU

TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

ABRIDGED BALANCE SHEET
30 NOVEMBER 2023

2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 14,775 15,405

CURRENT ASSETS
Stocks 100,000 76,000
Debtors 18,911 2,884
Cash at bank 15,902 5,252
134,813 84,136
CREDITORS
Amounts falling due within one year 33,798 22,824
NET CURRENT ASSETS 101,015 61,312
TOTAL ASSETS LESS CURRENT
LIABILITIES

115,790

76,717

CREDITORS
Amounts falling due after more than one
year

5

(15,109

)

(17,370

)

PROVISIONS FOR LIABILITIES (3,530 ) (2,771 )
NET ASSETS 97,151 56,576

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 97,051 56,476
97,151 56,576

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

ABRIDGED BALANCE SHEET - continued
30 NOVEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Income and Retained Earnings and an abridged Balance Sheet for the year ended 30 November 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 20 August 2024 and were signed by:





Mr. B. M. Clarke - Director


TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023


1. STATUTORY INFORMATION

Total Bleed Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the sale of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 5 ) .

4. TANGIBLE FIXED ASSETS
Totals
£
COST
At 1 December 2022 31,518
Additions 3,893
At 30 November 2023 35,411
DEPRECIATION
At 1 December 2022 16,113
Charge for year 4,523
At 30 November 2023 20,636
NET BOOK VALUE
At 30 November 2023 14,775
At 30 November 2022 15,405

TOTAL BLEED SOLUTIONS LIMITED (REGISTERED NUMBER: 10497591)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023


4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Totals
£
COST
At 1 December 2022 962
Additions 1,599
At 30 November 2023 2,561
DEPRECIATION
At 1 December 2022 221
Charge for year 321
At 30 November 2023 542
NET BOOK VALUE
At 30 November 2023 2,019
At 30 November 2022 741

5. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN FIVE
YEARS
2023 2022
£ £
Repayable by instalments
Bank loans 4,540 7,016